Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatment.
about
Tumour Cell HeterogeneityA novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestineA panoply of errors: polymerase proofreading domain mutations in cancerMutanome and expression of immune response genes in microsatellite stable colon cancerImportant molecular genetic markers of colorectal cancer.Cancer predisposition syndromes: lessons for truly precision medicine.Replicative DNA polymerase defects in human cancers: Consequences, mechanisms, and implications for therapy.Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway.Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology.Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies.Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma.Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant Entity.POLE somatic mutations in advanced colorectal cancer.Colorectal Cancers: An Update on Their Molecular Pathology.Functional Analysis of Cancer-Associated DNA Polymerase ε Variants in Saccharomyces cerevisiae.Immunotherapy for Colorectal Cancer.Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.Mutational signature distribution varies with DNA replication timing and strand asymmetry
P2860
Q26765895-CA9E3361-883E-4A3C-A4AB-E0B2DDCC6C68Q28260241-A327538F-9986-4EA6-A224-B6169AA9F38CQ28272700-65D2ED69-9356-48FE-91F3-89331E3404E3Q37109573-B7072828-89AD-40D3-9647-E7291A37DCAAQ37619856-19496708-30AC-4AA4-A9B5-EEF3F0824028Q39012229-A3ACF602-BBE1-47E2-8E26-ADD81C021C73Q39421725-FDC700ED-644E-46A2-91F9-40A6E3814961Q39580452-540DC4DC-7C53-4B9A-A116-4562892659F0Q39967039-8CAFF29D-1E8F-461B-8A8B-8AD8290FC748Q40228878-E9CAA181-8BAA-4FD8-9D28-DA6320F47B94Q40401895-8766B8F2-B36E-4DC9-B59E-1A944DFD77C6Q46364204-B0296B25-6C22-4767-A8D8-5C2B2A694648Q47862551-C22BB431-1A54-4D6A-BCFD-EAB1666EBD13Q48125044-91D35542-A8B1-4373-85A5-8EE49367D271Q48182864-ED854CC6-0564-4761-B694-9ED461EB01B1Q49911660-2EBB6C74-BD8B-4529-B393-424550E3E65AQ53111596-C9F27D7A-B566-434B-8078-6421D0FBE753Q53522728-FEAAA732-44EE-49C9-BE42-3F637982F0D3Q58756653-E6D04B2E-F6A4-43EF-8A82-DE819A06999A
P2860
Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mutations in POLE and survival ...... o disease stage and treatment.
@ast
Mutations in POLE and survival ...... o disease stage and treatment.
@en
Mutations in POLE and survival ...... o disease stage and treatment.
@nl
type
label
Mutations in POLE and survival ...... o disease stage and treatment.
@ast
Mutations in POLE and survival ...... o disease stage and treatment.
@en
Mutations in POLE and survival ...... o disease stage and treatment.
@nl
prefLabel
Mutations in POLE and survival ...... o disease stage and treatment.
@ast
Mutations in POLE and survival ...... o disease stage and treatment.
@en
Mutations in POLE and survival ...... o disease stage and treatment.
@nl
P2093
P2860
P50
P356
P1433
P1476
Mutations in POLE and survival ...... o disease stage and treatment.
@en
P2093
Albrecht Stenzinger
Esther Herpel
Hendrik Bläker
Matthias Kloor
Nicole Pfarr
Roland Penzel
Thomas Wolf
Volker Endris
Wilfried Roth
P2860
P304
P356
10.1002/CAM4.305
P407
P50
P577
2014-08-01T00:00:00Z